quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:44:00·665d
PRRelease
Protagonist Therapeutics Inc. logo
S&P Global Inc. logo
Encore Wire Corporation logo

Protagonist Therapeutics Set to Join S&P SmallCap 600

PTGX· Protagonist Therapeutics Inc.SPGI· S&P Global Inc.WIRE· Encore Wire Corporation
Health CareFinanceIndustrials
Original source

Companies

  • PTGX
    Protagonist Therapeutics Inc.
    Health Care
  • SPGI
    S&P Global Inc.
    Finance
  • WIRE
    Encore Wire Corporation
    Industrials

Recent analyst ratings

  • Feb 17SPGIUpdateBofA Securities$575.00
  • Oct 1SPGIUpdateSeaport Research Partners$540.00
  • Sep 17PTGXUpdateBarclays$72.00
  • Sep 12PTGXUpdateLeerink Partners$73.00
  • Jun 17PTGXUpdateCitigroup$72.00
  • Apr 10SPGIUpdateBofA Securities$600.00

Related

  • PR7h
    S&P Dow Jones Indices Announces Dow Jones Best-in-Class Indices 2026 Review Results
  • INSIDER2d
    SEC Form 4 filed by Ali Asif
  • PR2d
    S&P Global Energy and United Nations Sustainable Stock Exchanges are Collaborating to Advance the Energy Transition in Capital Markets
  • NEWS7d
    Protagonist Therapeutics Reports Granting of Inducement Awards
  • PR9d
    CARFAX: Used Car Prices Spike after Hitting 12-Month Low
  • PR10d
    CARFAX Named Top Workplace by USA Today and Best Places to Work in Virginia
  • PR10d
    S&P Global Market Intelligence's 2026 Private Equity Survey Shows Fundraising Confidence Rising as Managers Pivot to Operational Value
  • PR16d
    S&P Global Expands U.S. Employee Benefits By Matching Federal Government Contributions to Child Savings Accounts
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022